Endocrine Journal · 2017 · 14 citations · 7 references
To explore the role of NF-κB activation in the development of insulin resistance and investigate whether or not that the inhibition of NF-κB activation by PDTC will improve the insulin resistance of L6 cells exposed to H<sub>2</sub>O<sub>2</sub>. L6 cells were treated with H<sub>2</sub>O<sub>2</sub>, PDTC or both H<sub>2</sub>O<sub>2</sub> and PDTC for 4 hours. The uptake of glucose with stimulation of insulin, the expression of P38-MAPK, p- P38-MAPK, NF-κBp65, p- NF-κBp65, IRS-1, IRS-2, p-IRS-2, PI3K, IκBα, p- IκBα, caspase-8 and GLUT4, the production of ROS, TNF-α, IL-6 and IL-1β as well as the apoptosis rate of L6 cells were determined and compared in L6 treated with H<sub>2</sub>O<sub>2</sub> alone or both H<sub>2</sub>O<sub>2</sub> and PDTC. Compared with the L6 cells treated with H<sub>2</sub>O<sub>2</sub> alone, the L6 cells treated with both H<sub>2</sub>O<sub>2</sub> and PDTC showed (1) significantly lower production of ROS, TNF-α, IL-6 and IL-1β; (2) significantly decreased expression of P38-MAPK, p- P38-MAPK and NF-κBp65, p- NF-κBp65, p- IκBα and caspase-8; (3) significantly lower rate of apoptosis; (4) significantly higher expression of IRS-2, p-IRS-2 (Tyr 612), PI3K and GLUT4; (5) significantly higher uptake of glucose with stimulation of insulin; (6) significantly increased expression of Bcl2 and decreased ratio of Bax to Bcl2. Based on the findings of the present study, inhibition of NF-κB activation by PDTC would improve the insulin resistance of L6 cells exposed to H<sub>2</sub>O<sub>2</sub>.
7
Sarah H. Wild, Gojka Roglić, Anders Green et al. · Diabetes Care · 2004 · 15.2K citations
Takehide Ogihara, Tomoichiro Asano, Hideki Katagiri et al. · Diabetologia · 2004 · 146 citations · Full text
Metabolic Remodeling, Insulin Signaling, Nuclear Factor- +17
Troglitazone Induces GLUT4 Translocation in L6 Myotubes
Shin Yonemitsu, Haruo Nishimura, Mitsuyo Shintani et al. · Diabetes · 2001 · 142 citations · Full text